Molecular genetic heterogeneity in autosomal dominant drusen

E. E. Tarttelin, C. Y. Gregory-Evans, A. C. Bird, Richard Weleber, Michael Klein, J. Blackburn, K. Gregory-Evans

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective - Autosomal dominant drusen is of particular interest because of its phenotypic similarity to age related macular degeneration. Currently, mutation R345W of EFEMP1 and, in a single pedigree, linkage to chromosome 6q14 have been causally related to the disease. We proposed to investigate and quantify the roles of EFEMP1 and the 6q14 locus in dominant drusen patients from the UK and USA. Design - Molecular genetic analysis. Participants - Ten unrelated families and 17 young drusen patients. Main outcome measures - Exons 1 and 2 of EFEMP1 were characterised by 5′ rapid amplification of cDNA ends and direct sequencing. Exons 1-12 of EFEMP1 were then investigated for mutation by direct sequencing. A HpaII restriction digest test was constructed to detect the EFEMP1 R345W mutation. Marker loci spanning the two dominant drusen linked loci were used to generate haplotype data. Results - Only seven of the 10 families (70%) and one of the 17 sporadic patients (6%) had the R345W mutation. The HpaII restriction digest test was found to be a reliable and quick method for detecting this. No other exonic or splice site mutation was identified. Of the three families without EFEMP1 mutation, two were linked to the 2p16 region. Conclusions - EFEMP1 R345W accounts for only a proportion of the dominant drusen phenotype. Importantly, other families linked to chromosome 2p16 raise the possibility of EFEMP1 promoter sequence mutation or a second dominant drusen gene at this locus. Preliminary haplotype data suggest that the disease gene at the 6q14 locus is responsible for only a minority of dominant drusen cases.

Original languageEnglish (US)
Pages (from-to)381-384
Number of pages4
JournalJournal of Medical Genetics
Volume38
Issue number6
StatePublished - 2001

Fingerprint

Genetic Heterogeneity
Molecular Biology
Mutation
Haplotypes
Exons
Chromosomes
Dominant Genes
Macular Degeneration
Pedigree
Complementary DNA
Outcome Assessment (Health Care)
Phenotype
Genes

Keywords

  • Autosomal dominant drusen
  • Molecular genetics

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Tarttelin, E. E., Gregory-Evans, C. Y., Bird, A. C., Weleber, R., Klein, M., Blackburn, J., & Gregory-Evans, K. (2001). Molecular genetic heterogeneity in autosomal dominant drusen. Journal of Medical Genetics, 38(6), 381-384.

Molecular genetic heterogeneity in autosomal dominant drusen. / Tarttelin, E. E.; Gregory-Evans, C. Y.; Bird, A. C.; Weleber, Richard; Klein, Michael; Blackburn, J.; Gregory-Evans, K.

In: Journal of Medical Genetics, Vol. 38, No. 6, 2001, p. 381-384.

Research output: Contribution to journalArticle

Tarttelin, EE, Gregory-Evans, CY, Bird, AC, Weleber, R, Klein, M, Blackburn, J & Gregory-Evans, K 2001, 'Molecular genetic heterogeneity in autosomal dominant drusen', Journal of Medical Genetics, vol. 38, no. 6, pp. 381-384.
Tarttelin EE, Gregory-Evans CY, Bird AC, Weleber R, Klein M, Blackburn J et al. Molecular genetic heterogeneity in autosomal dominant drusen. Journal of Medical Genetics. 2001;38(6):381-384.
Tarttelin, E. E. ; Gregory-Evans, C. Y. ; Bird, A. C. ; Weleber, Richard ; Klein, Michael ; Blackburn, J. ; Gregory-Evans, K. / Molecular genetic heterogeneity in autosomal dominant drusen. In: Journal of Medical Genetics. 2001 ; Vol. 38, No. 6. pp. 381-384.
@article{5de53d707f904b1eba72bf0bc675df21,
title = "Molecular genetic heterogeneity in autosomal dominant drusen",
abstract = "Objective - Autosomal dominant drusen is of particular interest because of its phenotypic similarity to age related macular degeneration. Currently, mutation R345W of EFEMP1 and, in a single pedigree, linkage to chromosome 6q14 have been causally related to the disease. We proposed to investigate and quantify the roles of EFEMP1 and the 6q14 locus in dominant drusen patients from the UK and USA. Design - Molecular genetic analysis. Participants - Ten unrelated families and 17 young drusen patients. Main outcome measures - Exons 1 and 2 of EFEMP1 were characterised by 5′ rapid amplification of cDNA ends and direct sequencing. Exons 1-12 of EFEMP1 were then investigated for mutation by direct sequencing. A HpaII restriction digest test was constructed to detect the EFEMP1 R345W mutation. Marker loci spanning the two dominant drusen linked loci were used to generate haplotype data. Results - Only seven of the 10 families (70{\%}) and one of the 17 sporadic patients (6{\%}) had the R345W mutation. The HpaII restriction digest test was found to be a reliable and quick method for detecting this. No other exonic or splice site mutation was identified. Of the three families without EFEMP1 mutation, two were linked to the 2p16 region. Conclusions - EFEMP1 R345W accounts for only a proportion of the dominant drusen phenotype. Importantly, other families linked to chromosome 2p16 raise the possibility of EFEMP1 promoter sequence mutation or a second dominant drusen gene at this locus. Preliminary haplotype data suggest that the disease gene at the 6q14 locus is responsible for only a minority of dominant drusen cases.",
keywords = "Autosomal dominant drusen, Molecular genetics",
author = "Tarttelin, {E. E.} and Gregory-Evans, {C. Y.} and Bird, {A. C.} and Richard Weleber and Michael Klein and J. Blackburn and K. Gregory-Evans",
year = "2001",
language = "English (US)",
volume = "38",
pages = "381--384",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - Molecular genetic heterogeneity in autosomal dominant drusen

AU - Tarttelin, E. E.

AU - Gregory-Evans, C. Y.

AU - Bird, A. C.

AU - Weleber, Richard

AU - Klein, Michael

AU - Blackburn, J.

AU - Gregory-Evans, K.

PY - 2001

Y1 - 2001

N2 - Objective - Autosomal dominant drusen is of particular interest because of its phenotypic similarity to age related macular degeneration. Currently, mutation R345W of EFEMP1 and, in a single pedigree, linkage to chromosome 6q14 have been causally related to the disease. We proposed to investigate and quantify the roles of EFEMP1 and the 6q14 locus in dominant drusen patients from the UK and USA. Design - Molecular genetic analysis. Participants - Ten unrelated families and 17 young drusen patients. Main outcome measures - Exons 1 and 2 of EFEMP1 were characterised by 5′ rapid amplification of cDNA ends and direct sequencing. Exons 1-12 of EFEMP1 were then investigated for mutation by direct sequencing. A HpaII restriction digest test was constructed to detect the EFEMP1 R345W mutation. Marker loci spanning the two dominant drusen linked loci were used to generate haplotype data. Results - Only seven of the 10 families (70%) and one of the 17 sporadic patients (6%) had the R345W mutation. The HpaII restriction digest test was found to be a reliable and quick method for detecting this. No other exonic or splice site mutation was identified. Of the three families without EFEMP1 mutation, two were linked to the 2p16 region. Conclusions - EFEMP1 R345W accounts for only a proportion of the dominant drusen phenotype. Importantly, other families linked to chromosome 2p16 raise the possibility of EFEMP1 promoter sequence mutation or a second dominant drusen gene at this locus. Preliminary haplotype data suggest that the disease gene at the 6q14 locus is responsible for only a minority of dominant drusen cases.

AB - Objective - Autosomal dominant drusen is of particular interest because of its phenotypic similarity to age related macular degeneration. Currently, mutation R345W of EFEMP1 and, in a single pedigree, linkage to chromosome 6q14 have been causally related to the disease. We proposed to investigate and quantify the roles of EFEMP1 and the 6q14 locus in dominant drusen patients from the UK and USA. Design - Molecular genetic analysis. Participants - Ten unrelated families and 17 young drusen patients. Main outcome measures - Exons 1 and 2 of EFEMP1 were characterised by 5′ rapid amplification of cDNA ends and direct sequencing. Exons 1-12 of EFEMP1 were then investigated for mutation by direct sequencing. A HpaII restriction digest test was constructed to detect the EFEMP1 R345W mutation. Marker loci spanning the two dominant drusen linked loci were used to generate haplotype data. Results - Only seven of the 10 families (70%) and one of the 17 sporadic patients (6%) had the R345W mutation. The HpaII restriction digest test was found to be a reliable and quick method for detecting this. No other exonic or splice site mutation was identified. Of the three families without EFEMP1 mutation, two were linked to the 2p16 region. Conclusions - EFEMP1 R345W accounts for only a proportion of the dominant drusen phenotype. Importantly, other families linked to chromosome 2p16 raise the possibility of EFEMP1 promoter sequence mutation or a second dominant drusen gene at this locus. Preliminary haplotype data suggest that the disease gene at the 6q14 locus is responsible for only a minority of dominant drusen cases.

KW - Autosomal dominant drusen

KW - Molecular genetics

UR - http://www.scopus.com/inward/record.url?scp=0034979562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034979562&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 381

EP - 384

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

IS - 6

ER -